Protocol Ledger

NCT06664775 · Phase III · RECRUITING

A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

Interventional Phase III clinical trial protocol NCT06664775 sponsored by Corza Medical in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-04-02 Enrollment: 116 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06664775
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)116 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06664775
Protocol FieldVerified Registry Value
NCT IdentifierNCT06664775
Consolidated Lead SponsorCorza Medical
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment116 participants (ESTIMATED)
Registered Start Date2025-04-02
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06664775
Hospital Research SiteLocationSite Profile
University of Chicago MedicineChicago, ILOpen Hospital Dossier ->
Indiana UniversityIndianapolis, INOpen Hospital Dossier ->
University of LouisvilleLouisville, KYOpen Hospital Dossier ->
Washington University and Siteman Cancer CenterSaint Louis, MOOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI